Optimization of Treatment With Adalimumab (Humira)

This study has been completed.

Sponsor:

Collaborator:

Abbott

Information provided by (Responsible Party):

Janet Pope, Lawson Health Research Institute

ClinicalTrials.gov Identifier:

NCT01585064

First received: April 23, 2012

Last updated: April 24, 2012

Last verified: April 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	February 2010
Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)

No publications provided by Lawson Health Research Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Pope J, Thorne JC, Haraoui BP, Psaradellis E, Sampalis J. Do patients with active RA have differences in disease activity and perceptions if anti-TNF naïve versus anti-TNF experienced? Baseline results of the optimization of adalimumab trial. Med Sci Monit. 2012 Aug;18(8):PI17-20.

To Top